Clinical trial
Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
NCT01311557 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Immunogenicity of Adacel® Vaccine Administered to Persons 10 Years of Age
- Lead sponsor
- Sanofi
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2011
- Completion date
- January 31, 2012
- Enrollment
- 1,302 (actual)
- Sites
- 34
Conditions
As the registry lists them; a condition with its own page is linked.
diphtheria, pertussis, tetanus